Newsletter | February 9, 2021

02.09.21 -- New Drug For Aggressive Brain Cancer Enters Clinical Trials

Sponsor

Industry Insights

Stripping And Reprobing Western Blot Membrane: Problems And Solutions

Article | Cytiva

Ways of maximizing your Western blot membrane use by stripping and reprobing with another primary antibody.

Expediting Viral-Based Vaccines Development And Increasing Productivity

Webinar | Sartorius Stedim Biotech

This presentation describes how vaccine developers can accelerate their timelines and develop highly efficient vaccine processes using multi-parallel bioreactor testing tools, DoE software, and single-use solutions.

Most Popular News

• New Drug For Aggressive Brain Cancer Enters Clinical Trials

• Pharmacologist Offers Plan To Solve Disparities In Designing Medicines That Work For All

• X-Chem Forms Multitarget Oncology Discovery Research Collaboration With Genentech

• ZebiAI And TB Alliance Collaborate To Apply ML-Driven Discovery Platform To TB Targets

• Ascentage Pharma Announces Fifth ODD Granted To Bcl-2 Inhibitor APG-2575

• BioCryst Announces FDA Approval Of sNDA For RAPIVAB Including Children Over Six Months

• Theratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation

• Verista Acquires Hawkins Point

• MAX BioPharma Announces Discoveries Regarding Drug Candidates For Targeting COVID-19

• Aeterna Zentaris Expands ODD Pipeline With Targeted Immunosuppressive Therapeutics

• PerkinElmer’s Horizon Discovery CHOSOURCE Cell Line Supports Trinomab Biotech’s Development Of Tetanus Toxin mAb Drug For Clinical Trials

Solutions

How Leveraging A Global Network Delivered Big Results

Thermo Fisher Scientific

DPI Formulation Development And Manufacturing

Lonza

Life Science Leader Magazine


		Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business.

This website uses cookies to ensure you get the best experience on our website. Learn more